Fenucure Medical ApS
CVR 28486871 · Private limited company (ApS) · Active · Low risk
Fenucure Medical ApS is a Private limited company (ApS), founded on , based in Kongens Lyngby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.0% over the next 12 months, which is 0.7 times the average for Danish companies. 20 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 594k and a net result of DKK -3.2m.
Bankruptcy risk for Fenucure Medical ApS
0.7 × the average (1.41%) · higher risk than 72% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 28486871
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (21 years)
- Address
- Nymøllevej 50
2800 Kongens Lyngby - Municipality
- Lyngby-Taarbæk
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 400k
- Employees
- 0 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 20 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 30.2% |
| Current ratio | 288% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 40 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -1.2m | DKK -873k | DKK -912k |
| Net profit | DKK -3.2m | DKK -1.5m | DKK -2.1m |
| Equity | DKK 594k | DKK 795k | DKK -1.7m |
| Total assets | DKK 2.0m | DKK 3.3m | DKK 1.5m |
| Cash | DKK 501k | DKK 769k | – |
| Short-term debt | DKK 667k | DKK 903k | – |
| Avg. employees | 2 | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 146 | ||
| 1 Jan 2024 – 31 Dec 2024 | 155 | ||
| 1 Jan 2023 – 31 Dec 2023 | 150 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 124 | ||
| 1 Jan 2020 – 31 Dec 2020 | 110 | ||
| 1 Jul 2018 – 31 Dec 2019 | 122 | ||
| 1 Jul 2017 – 30 Jun 2018 | 156 | ||
| 1 Jul 2016 – 30 Jun 2017 | 164 | ||
| 1 Jul 2015 – 30 Jun 2016 | 147 | ||
| 1 Jul 2014 – 30 Jun 2015 | 169 | ||
| 1 Jul 2013 – 30 Jun 2014 | 176 | ||
| 1 Jul 2012 – 30 Jun 2013 | 174 | ||
| 1 Jul 2011 – 30 Jun 2012 | 164 | ||
| 1 Jul 2010 – 30 Jun 2011 | 160 | ||
| 1 Jul 2009 – 30 Jun 2010 | 152 | ||
| 1 Jul 2008 – 30 Jun 2009 | 155 | ||
| 1 Jan 2007 – 31 Dec 2007 | 163 | ||
| 1 Jan 2006 – 31 Dec 2006 | 178 | ||
| 14 Feb 2005 – 31 Dec 2005 | 184 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Holger Lunden | ||
| CEO | Philip Xavier Severin Møller | ||
| Board | Alex Gundersen | Current | |
| Board | Nicolai Fink Gundersen | Current | |
| Board | Niels Christian Beck Vase | Current | |
| Board | Mogens Viktor Madsen | Current | |
| Board | Jens Steen Olsen | ||
| Board | Preben Andersen | ||
| Board | Jørgen Schönherr | ||
| Owner (67%) | Alex Gundersen Assens ApS | Current | |
| Owner (5%) | V-BIOTEK HOLDING ApS | Current | |
| Owner (5%) | Redwood Foundation ApS | Current | |
| Owner (33%) | V-BIOTEK HOLDING ApS | ||
| Owner (50%) | ALEX GUNDERSEN TOBACCO COMPANY AKTIESELSKAB | ||
| Owner (50%) | AGTC 2019 ApS | ||
| Owner (50%) | Alex Gundersen Assens ApS | ||
| Owner (15%) | V-BIOTEK HOLDING ApS | ||
| Owner (15%) | Redwood Foundation ApS | ||
| Owner (15%) | V-BIOTEK HOLDING ApS | ||
| Owner (10%) | Redwood Foundation ApS | ||
| Owner (10%) | V-BIOTEK HOLDING ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | LandboNord F.M.B.A. | ||
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | VKST REVISION, GODKENDT REVISIONSAKTIESELSKAB | ||
| Founder | Holger Lunden | Current |
The CEOs' other companies
Holger Lunden – 8 other companies
- CAD Rooms ApS Active
- DaHoMi Real Estate Partners ApS Active
- IMOTIONS A/S Active
- Lunden Energy ApS Active
- P-BIOTEK ApS Opløst
- PlatoScience ApS Active
- QUR Medical ApS Active
- ROVSING GREEN ENERGY A/S Opløst
Philip Xavier Severin Møller – 9 other companies
- BEL-INVEST ApS Fusioneret
- COPENHAGEN CARE A/S Opløst
- DEMO CONSULT & INVEST ApS Compulsorily dissolved
- DUOS A/S Active
- EJENDOMSAKTIESELSKABET AF 1/6 1992 Opløst
- EJENDOMSFINANS A/S Compulsorily dissolved
- HANDIBYG ApS Compulsorily dissolved
- HANDIGROUP ApS Opløst
- PAIA HOLDING ApS Active
Address history (4 moves)
| Nymøllevej 50, 2800 Kongens Lyngby | |
| Ørsted Bygade 5, 4622 Havdrup | |
| c/o Advokat Carlo Siebert, Vimmelskaftet 43, 1161 København K | |
| c/o Advokat Robert Mikelsons, Eversheds, Østergade 27, 3., 1100 København K | |
| c/o Holger Lunden, Thorvaldsensvej 29B, st. th, 1871 Frederiksberg C |
Former names
| Fenucure Medical ApS | – now |
| V-BIOTEK ApS | – |
| VIND INVEST ApS | – |
Employees per year
Other companies at the same address
- AKTIESELSKABET TACITUS Active
- Agora Sourcing ApS Active
- BLACHMAN ApS Active
- COMEPLOT ApS Active
- COMPLET DATA A/S Fusioneret
- CitNOW Nordic A/S Active
- Companial Nordics A/S Active
- DB24 DK ApS Active
- Dansk Storkøb ApS Opløst
- DecisionMaking ApS Active
- DistanceRunning.dk ApS Active
- Dokumenter.dk ApS Active
- EDELWEISS HOLDINGS ApS Active
- EJENDOMSAKTIESELSKABET DOMVS PORTVS Active
- Ejd. Udviklingsselskabet Rådmandshaven Komplementar ApS Active
- J. H. ADMINISTRATION A/S Active
- JJ Rosholm Holding ApS Fusioneret
- LITEHAUZ ApS Active
- NICK HOLDING ApS Active
- OCH Risikorådgivning ApS Active
- OCH Rådgivning ApS Active
- Popl ApS Active
- PrivatretsAdvokaterne ApS Active
- Rådmandshaven Holding 1 ApS Active
- Rådmandshaven Holding 2 ApS Active
Similar companies in Lyngby-Taarbæk
- Munro Consulting ApS Kongens Lyngby
- Nykode Tolerance A/S Kongens Lyngby
- Mycoverse ApS Kongens Lyngby
- Enzidia ApS Kongens Lyngby
- Novo Nordisk Foundation Cellerator A/S Kongens Lyngby
- KLMBio ApS Virum
- MCT Bioseparation Aps Kongens Lyngby
- VenomAid Diagnostics ApS Kongens Lyngby
- Valinor Aps Kongens Lyngby
- GeCo ApS Kongens Lyngby
- Selma Diagnostics ApS Kongens Lyngby
- MonTa Biosciences ApS Kongens Lyngby
Questions and answers about Fenucure Medical ApS
Has Fenucure Medical ApS gone bankrupt?
No, Fenucure Medical ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Fenucure Medical ApS?
Our model estimates a bankruptcy risk of 1.0% over the next 12 months (low risk), which is 0.7 times the average for Danish companies.
Who is the auditor of Fenucure Medical ApS?
Fenucure Medical ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Fenucure Medical ApS founded?
Fenucure Medical ApS was founded on 14 February 2005.
What is the equity of Fenucure Medical ApS?
Equity was DKK 594k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.